Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

GSK - Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

Chair interview of Dr. Leary: Perspective on identifying patients with dMMR endometrial cancer for ICI treatment

Date

11 Sep 2022

Session

GSK - Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

Topics

Tumour Site

Endometrial Cancer

Presenters

Alexandra Leary

Authors

A. Leary

Author affiliations

Medicine Dept., Institut Gustave Roussy, 94805 - Villejuif, Cedex/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

11 Sep 2022

Clinical considerations for ICI treatment of dMMR endometrial cancer and other dMMR solid tumors

Presenter: All Speakers

Session: GSK - Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

Resources:

Webcast

11 Sep 2022

Chair interview of Dr. Cercek: Perspective on single-agent PD-1 blockade in dMMR CRC/solid tumors

Presenter: Andrea Cercek

Session: GSK - Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

Resources:

Webcast

11 Sep 2022

Panel discussion: Considerations for ICI treatment of dMMR endometrial cancer and CRC/solid tumors, expert perspectives

Presenter: Andrea Cercek

Session: GSK - Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

Resources:

Webcast

11 Sep 2022

Q&A

Presenter: Andrea Cercek

Session: GSK - Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

Resources:

Webcast